Noxafil and Colistimethate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Noxafil (posaconazole) and Colistimethate (colistimethate sodium). Common drug interactions include dysphonia among females and influenza among males.

The phase IV clinical study analyzes what interactions people have when they take Noxafil and Colistimethate. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Noxafil?

Noxafil has active ingredients of posaconazole. eHealthMe is studying from 5,919 Noxafil users. Check the latest studies of Noxafil.

What is Colistimethate?

Colistimethate has active ingredients of colistimethate sodium. eHealthMe is studying from 1,502 Colistimethate users. Check the latest studies of Colistimethate.

On Aug, 03, 2026

25 people who take Noxafil and Colistimethate together, and have interactions are studied.

Noxafil and Colistimethate drug interactions.

What are the common drug interactions of Noxafil and Colistimethate, by gender? *:

female:

Dysphonia (speech disorder attributable to a disorder of phonation)
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Sinusitis (inflammation of sinus)
Sinus congestion (blockage of sinus)
Acne (skin problems that cause pimples)
Asthenia (weakness)
Azotaemia (excess of urea or other nitrogenous compounds in the blood)
Bacteraemia (presence of bacteria in the blood)
Decreased appetite
Dehydration (dryness resulting from the removal of water)

male:

Influenza
Respiratory failure (inadequate gas exchange by the respiratory system)
Hypervolaemia (abnormally increased volume of blood)
Multi-organ failure (multisystem organ failure)
Oedema (fluid collection in tissue)
Oliguria (not enough urine)
Abdominal pain upper
Aggression
Anxiety
Cystic fibrosis (disease of the secretary glands)

What are the common drug interactions of Noxafil and Colistimethate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Aggression
Anxiety
Panic attack

20-29:

Septic shock (shock due to blood infection)
Venoocclusive liver disease (small veins in the liver are obstructed)
Abdominal pain upper
Arthralgia (joint pain)
Cystic fibrosis (disease of the secretary glands)
Dermatitis psoriasiform (large white or silver flakes on the skin)
Eye abscess
Forced expiratory volume decreased (decreased lung expired air volume)
Hepatotoxicity (chemical-driven liver damage)
Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)

30-39:

Dysphonia (speech disorder attributable to a disorder of phonation)
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Sinusitis (inflammation of sinus)
Respiratory failure (inadequate gas exchange by the respiratory system)
Acne (skin problems that cause pimples)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Malaise (a feeling of general discomfort or uneasiness)
Sinus congestion (blockage of sinus)
Vision blurred
Acute lymphocytic leukaemia (cancer of the white blood cells)

40-49:

Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)

50-59:

Influenza
Hospitalisation
Skin lesion

60+:

Asthenia (weakness)
Azotaemia (excess of urea or other nitrogenous compounds in the blood)
Oral fungal infection
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Pneumonia
Stomatitis (inflammation of mucous membrane of mouth)
Intervertebral disc protrusion (spinal disc protrusion)
Intestinal haemorrhage (bleeding from intestine)
Renal failure (kidney dysfunction)
Bacteraemia (presence of bacteria in the blood)

What are the existing conditions these people have? *

Cystic Fibrosis (disease of the secretary glands): 14 people, 56.00%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 4 people, 16.00%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 2 people, 8.00%
Diarrhea: 2 people, 8.00%
Cystic Fibrosis Lung (fibrosis with cyst in the lung): 2 people, 8.00%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 8.00%
Bacteraemia (presence of bacteria in the blood): 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Noxafil and Colistimethate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously